Kenvue Inc. Declares Quarterly Dividend of $0.2075 per Share
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Businesswire
- Quarterly Dividend Announcement: Kenvue Inc.'s Board of Directors declared a quarterly dividend of $0.2075 per share, payable on February 25, 2026, reflecting the company's commitment to returning value to shareholders.
- Record Date for Shareholders: The record date for this dividend is set for February 11, 2026, ensuring that investors holding shares by this date will receive the dividend, which enhances investor confidence.
- Market Position: Kenvue is the world's largest pure-play consumer health company by revenue, showcasing strong market competitiveness and brand influence with iconic brands like Aveeno, BAND-AID, Johnson’s, Listerine, Neutrogena, and Tylenol.
- Brand Influence: Kenvue's brands are science-backed and recommended by healthcare professionals globally, further solidifying its leadership position in the consumer health sector and driving sustainable long-term growth.
Analyst Views on KVUE
Wall Street analysts forecast KVUE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KVUE is 18.86 USD with a low forecast of 17.00 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
1 Buy
7 Hold
0 Sell
Hold
Current: 17.640
Low
17.00
Averages
18.86
High
23.00
Current: 17.640
Low
17.00
Averages
18.86
High
23.00
About KVUE
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
